Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
21 Leser
Artikel bewerten:
(0)

Partnership Expands Avalere's Reach Into EU Markets

-- Avalere-Pope Woodhead Collaboration a Natural Fit to Deliver Global Market Services.

WASHINGTON, Nov. 10, 2014 /PRNewswire/ -- Avalere Health is expanding internationally, offering a suite of services in reimbursement and health economics services for life sciences companies. Avalere has initiated a partnership with Pope Woodhead & Associates, a European-based consultancy with 30 years of expertise in partnering with life science companies. Their specialties include regulatory strategy, pricing and market access solutions for successful entry into European and emerging country markets.

The partnership will leverage each firm's best-in-class local market insight to enhance global strategies for clients in the areas of regulatory strategy, market access, value messaging, evidence generation planning and policy. The complementary nature of the partnership also will expand the geographic reach of Avalere's offerings in delivering client tools and solutions that reflect the values and priorities of the decision-makers in the U.S., European and emerging markets.

"Evidence is global, but healthcare decisions to purchase, prescribe and use technologies are local. Global life science companies must embrace a global view in how they think about data and evidence, but incorporate the local needs of each market," said Dan Mendelson, CEO of Avalere Health.

Avalere and Pope Woodhead's partnership will serve both firms' clients' goals to establish global evidence and research strategies that deliver highly valued innovations to patients around the world. In addition, each partner brings on-the-ground insight and deep investments in analytics of the payer, provider and prescriber trends in each country that lead to research, regulatory and commercial strategies that will resonate with decision-makers in each country.

"Over the last year, we successfully partnered with Avalere Health on a number of projects, thought leadership initiatives and client events. There is strong chemistry between our two teams and experience confirmed that formalizing this collaboration will add a lot of value to our clients, as well as being mutually beneficial to the development of each organization," said Andrew Hobbs, Managing Director, Pope Woodhead.

About Avalere Health
Avalere Health is a strategic advisory company whose core purpose is to create innovative solutions to complex healthcare problems. Based in Washington, D.C., the firm delivers actionable insights, business intelligence tools and custom analytics for leaders in healthcare business and policy. Avalere's experts span 180 staff drawn from Fortune 500 healthcare companies, the federal government (e.g., CMS, OMB, CBO and the Congress), top consultancies and nonprofits. The firm offers deep substance on the full range of healthcare business issues affecting the Fortune 500 healthcare companies. Avalere's focus on strategy is supported by a rigorous, in-house analytic research group that uses public and private data to generate quantitative insight. Through events, publications and interactive programs, Avalere insights are accessible to a broad range of customers. For more information, visit
avalere.com, or follow us on Twitter @avalerehealth.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.